Beacon Research Highlights Tech Laboratories, Inc. (TLBT.OB), as Company Signs LOI to Acquire Biodiesel Solutions, Inc.
The shares of Tech Laboratories, Inc. (TLBT.OB) advanced sharply Friday, up 37.5 percent, as the Company signs a Letter of…
Blog
StockGuru Blog: Tradequest International – Latin America Area of Major Growth – TRDQ Up as Much as 350% Since Coverage Initiated!
Tradequest Follows the Money by Moving into Latin America! TRDQ Up as Much as 350% Since Coverage Began TRDQ -…
May 28th CEOcast Weekly Newsletter
05/27/2007 VOLUME 301 Companies featured in the current edition of the newsletter: ARGA, AVGO, CHIP, CVM, CYTR, ENZ, GNBT, HSOA,…
StockGuru Blog: Visitrade- Online Trading with Low Prices and Unique Features
Low Prices - Unique Features Visitrade Website - VTDI CUTTING EDGE TRADING SYSTEM About Trading Clients will be able to…
Mizati Luxury Alloy Wheels, Inc. (OTC: MZTI.PK) Enters the Rent – To – Own (RTO) Marketplace
While Mizati Luxury Alloy Wheels, Inc. (OTC: MZTI.PK) previously announced its strategy to enter the Rent-To-Own (RTO) market with wheel…
Clearly Canadian Beverage Corporation (CCBEF.OB) is Clearly a Winner with Consumers
CCBEF has mastered the art of brand loyalty. As consumers demand great taste, CCBEF has leveraged flavor excellence to make…
Triple Crown Stocks Highlights the Rapidly Expanding Legendary Brand, Clearly Canadian Beverage Corporation (CCBEF.OB)
With a strong balance sheet as of April 30, 2007 reflecting over $7,000,000 in cash and no debt; Clearly Canadian Beverage…
Clearly Canadian Beverage Corp. (CCBEF.OB) Shares Corporate Status with Great Enthusiasm
Brent Lokash, President of Clearly Canadian Beverage, reported recent accomplishments as the company becomes a leader in the emerging organic…
Beacon Equity Research Highlights Tech Laboratories, Inc. (TLBT.OB)
Tech Laboratories is a company which supply’s the U.S. need for energy independence. Today it announced that they have signed…
Meyers Associates Projects a Price Target of $5 for Odyne Corp. (ODYC.OB)
Robert M. LeBoyer, Senior Biotechnology Analyst of Meyers Associates, gave Odyne an “Outperform” rating with a price target of $5…